Issue #237
- Saquinavir (Invirase): First Protease Inhibitor Approved -- Reimbursement, Information Hotline Numbers
- Abbott Protease Inhibitor Lottery in January, CD4 Under 50 -- Registration Now
- Abbott Protease Inhibitor: Early Results Reported
- Major Protease Inhibitor Triple Combination Trial Begins Soon: CD4 Under 200, AZT Experienced, 3TC Naive
- Wasting Syndrome: Oral Oxandrolone Re-Released in U.S.
- Lymphoma: MGBG New Studies, Compassionate Use in Earlier Disease
- Human Retroviruses, Immune-Based, and CPCRA Meetings, Washington D.C. Late January
- ACTG Clinical Trial Sites: Seven Cut, Two Added
- New York: Protease Inhibitor Forum, January 6
- Computer Censorship: Effect on AIDS TREATMENT NEWS
- AIDS TREATMENT NEWS Selected Index
source: AIDS Treatment News
